Occudo Quantitative Strategies LP Amgen Inc Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $353,210 - $404,217	-1,776 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $376,991 - $441,691	1,776 New	1,776 $378,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $205,932 - $239,980	-928 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $200,800 - $239,117	928 New	928 $213,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.